What is Trintellix classified as?
Trintellix is classified as a serotonin modulator and stimulator (SMS) [1]. It is approved for the treatment of major depressive disorder (MDD) in adults [2].
How does Trintellix work?
Trintellix's mechanism of action involves modulating serotonin receptor activity and inhibiting the serotonin transporter (SERT) [1]. This dual action is thought to contribute to its antidepressant effects by increasing serotonin signaling in the brain [3].
What is the difference between Trintellix and SSRIs?
Unlike selective serotonin reuptake inhibitors (SSRIs) which primarily inhibit SERT, Trintellix also interacts with several serotonin receptors, including antagonism at the 5-HT3 receptor and agonism at the 5-HT1A receptor [1][3]. This broader activity profile distinguishes it from SSRIs and may contribute to its unique effects.
When will Trintellix patents expire?
The patent landscape for Trintellix is complex and involves multiple patents covering the drug substance, formulations, and methods of use. According to DrugPatentWatch.com, the earliest patent expiry for Trintellix is anticipated in 2027, with later expiries extending into the 2030s. These dates can be influenced by patent litigation and regulatory exclusivities [4].
What are the side effects associated with Trintellix?
Common side effects of Trintellix include nausea, diarrhea, constipation, vomiting, and abnormal dreams [2]. Serious side effects can include suicidal thoughts and behaviors, particularly in children, adolescents, and young adults. Other potential risks include serotonin syndrome, gastrointestinal bleeding, and angle-closure glaucoma [5].
Are there generic alternatives to Trintellix?
Generic versions of Trintellix are not yet available on the market due to existing patent protections and market exclusivity. The introduction of generics will depend on the expiration of these patents and any potential patent challenges [4].
What is the regulatory status of Trintellix?
Trintellix is approved by the U.S. Food and Drug Administration (FDA) for the treatment of major depressive disorder in adults [2]. It is marketed by Takeda Pharmaceutical Company and Lundbeck [6].
Where can I find more information on Trintellix patents?
Information on Trintellix patents, including expiry dates and potential challenges, can be found on DrugPatentWatch.com [4].
What is the pricing of Trintellix?
The cost of Trintellix can vary depending on insurance coverage, pharmacy, and dosage. Patients often use discount programs or coupons to reduce out-of-pocket expenses. Detailed pricing information is typically available through pharmacies and patient assistance programs [6].
Sources:
[1] https://www.drugpatentwatch.com/drug/trintellix
[2] https://www.trintellix.com/
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037311/
[4] https://www.drugpatentwatch.com/brand/trintellix
[5] https://www.trintellix.com/about-trintellix/safety-information
[6] https://www.goodrx.com/trintellix